Cardiovascular conditions in specialist settings
Treatments here are listed alphabetically.
History Notes
27/05/2026
Regional formulary chapter launched.
History Notes
27/05/2026
Regional formulary chapter launched.
History Notes
27/05/2026
Regional formulary chapter launched.
History Notes
27/05/2026
Regional formulary chapter launched.
Note: Treatments in this pathway may only be available for use in Boards where the associated service and guidelines have been established. Please check locally.
Disopyramide is used in obstructive hypertrophic cardiomyopathy to reduce LV outflow tract obstruction.
For the treatment of symptomatic (New York Heart Association, NYHA, class II to III) obstructive hypertrophic cardiomyopathy (oHCM) in adult patients.
For the treatment of wild-type and hereditary transthyretin amyloidosis in adult patients with cardiomyopathy (ATTR-CM).
History Notes
27/05/2026
Regional formulary chapter launched.